apo-ENTERIT 760 mg/50mL
Citrullus colocynthis Fruit Pulp, Podophyllum, Veratrum album Root, Artemisia abrotanum Flowering Top, Cynara scolymus Whole, and Potentilla anserina Flowering Top · SOLUTION/ DROPS · PEKANA Naturheilmittel GmbH
apo-ENTERIT is a solution/ drops containing citrullus colocynthis fruit pulp, podophyllum, veratrum album root, artemisia abrotanum flowering top, cynara scolymus whole, and potentilla anserina flowering top at 760 mg/50mL, taken oral. Manufactured by PEKANA Naturheilmittel GmbH.
Key Facts
- Brand Name
- apo-ENTERIT
- Generic Name
- Citrullus colocynthis Fruit Pulp, Podophyllum, Veratrum album Root, Artemisia abrotanum Flowering Top, Cynara scolymus Whole, and Potentilla anserina Flowering Top
- NDC Code (Product)
59469-158- Manufacturer
- PEKANA Naturheilmittel GmbH
- Strength
- 760 mg/50mL
- Dosage Form
- SOLUTION/ DROPS
- Route
- ORAL
- Marketing Status
- Marketing Start
- 04/12/2008
Recall History
No Recall HistoryFrequently Asked Questions
What is apo-ENTERIT used for?
apo-ENTERIT contains Citrullus colocynthis Fruit Pulp, Podophyllum, Veratrum album Root, Artemisia abrotanum Flowering Top, Cynara scolymus Whole, and Potentilla anserina Flowering Top. It is a solution/ drops taken oral. Consult your doctor for specific uses.
Is apo-ENTERIT a controlled substance?
apo-ENTERIT is not classified as a controlled substance by the DEA.
What is the generic name for apo-ENTERIT?
The generic name for apo-ENTERIT is Citrullus colocynthis Fruit Pulp, Podophyllum, Veratrum album Root, Artemisia abrotanum Flowering Top, Cynara scolymus Whole, and Potentilla anserina Flowering Top. There are no other listed brand versions of Citrullus colocynthis Fruit Pulp, Podophyllum, Veratrum album Root, Artemisia abrotanum Flowering Top, Cynara scolymus Whole, and Potentilla anserina Flowering Top.
What is the NDC code for apo-ENTERIT 760 mg/50mL?
The NDC (National Drug Code) for apo-ENTERIT 760 mg/50mL is 59469-158, listed by PEKANA Naturheilmittel GmbH.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)